TAGS
remdesivir

Coronavirus: UAE approves Gilead’s COVID-19 drug remdesivir for patient use

Sunday, 05 July 2020

Gilead Sciences announced on Sunday that the UAE Ministry of Health and Prevention had granted ......

Coronavirus: Gilead COVID-19 drug remdesivir to cost $2,340 per patient

Monday, 29 June 2020

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will ......

Coronavirus: US drug pricing group raises price advisory for Gilead’s remdesivir

Thursday, 25 June 2020

Gilead Sciences Inc’s antiviral remdesivir could be priced up to $5,080 per course based on benefits ......

Remdesivir, favipiravir, famotidine: Discover coronavirus vaccines, drugs in progress

Tuesday, 26 May 2020

The race for treatments and vaccines against the coronavirus pandemic has continued to gather pace, ......

Coronavirus: US doctors call for remdesivir’s trial findings to guide treatment

Friday, 22 May 2020

US doctors and others in the scientific community are calling for the release of data that convinced ......

Gilead’s coronavirus drug remdesivir starts selling in Bangladesh

Thursday, 21 May 2020

Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start ......

Coronavirus: Gilead to end clinical studies of remdesivir

Saturday, 16 May 2020

Gilead Sciences’ two clinical studies of its potential coronavirus treatment remdesivir will wind ......

Coronavirus: India asked to rescind Gilead’s remdesivir patents for fair access

Thursday, 14 May 2020

Two health advocacy groups have written to the Indian government asking it to rescind patents given ......

Coronavirus: Gilead drug remdesivir sales could exceed $2 billion, say experts

Monday, 04 May 2020

At $4,500 for a round of treatment for COVID-19, remdesivir, Gilead Sciences Inc.’s new medicine ......

Remdesivir showed ‘no significant benefit’ in coronavirus patients

Wednesday, 29 April 2020

Treating coronavirus patients with the antiviral drug remdesivir showed no “significant clinical ......

Gilead drug remdesivir improved two-thirds of coronavirus cases: Study

Sunday, 12 April 2020

Gilead Sciences Inc.’s experimental drug for patients with severe COVID-19 infections showed promise ......

Top